1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Cebon, Jonathan S
Author:  Andrews, Miles C

Results 1-14 of 14 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
1Aug-2019A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases.Arulananda, Surein; Parakh, Sagun ; Palmer, Jodie ; Goodwin, Mark D ; Andrews, Miles C; Cebon, Jonathan S 
22018Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of IntralesionalBacillus Calmette-Guérinfollowed by Ipilimumab in Patients with Advanced Metastatic Melanoma.Da Gama Duarte, Jessica; Parakh, Sagun ; Andrews, Miles C; Woods, Katherine; Pasam, Anupama; Tutuka, Candani; Ostrouska, Simone; Blackburn, Jonathan M; Behren, Andreas; Cebon, Jonathan S 
328-Jun-2017PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation.Tutuka, Candani S A; Andrews, Miles C; Mariadason, John M ; Ioannidis, Paul; Hudson, Christopher; Cebon, Jonathan S ; Behren, Andreas
4Jun-2017Efficacy of anti-PD-1 therapy in patients with melanoma brain metastasesParakh, Sagun ; Park, John J; Mendis, Shehara; Rai, Rajat; Xu, Wen; Lo, Serigne; Drummond, Martin; Rowe, Catherine; Wong, Annie; McArthur, Grant; Haydon, Andrew; Andrews, Miles C; Cebon, Jonathan S ; Guminski, Alex; Kefford, Richard F; Long, Georgina V; Menzies, Alexander M; Klein, Oliver ; Carlino, Matteo S
511-Apr-2017Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.Bowyer, Samantha; Prithviraj, Prashanth; Lorigan, Paul; Larkin, James; McArthur, Grant; Atkinson, Victoria; Millward, Michael; Khou, Muoi; Diem, Stefan; Ramanujam, Sangeetha; Kong, Ben; Liniker, Elizabeth; Guminski, Alexander; Parente, Phillip; Andrews, Miles C; Parakh, Sagun ; Cebon, Jonathan S ; Long, Georgina V; Carlino, Matteo S; Klein, Oliver 
616-Nov-2016Systems analysis identifies miR-29b regulation of invasiveness in melanomaAndrews, Miles C; Cursons, Joseph; Hurley, Daniel G; Anaka, Matthew; Cebon, Jonathan S ; Behren, Andreas; Crampin, Edmund J
71-Dec-2015Cellular mechanisms underlying complete hematological response of chronic myeloid leukemia to BRAF and MEK1/2 inhibition in a patient with concomitant metastatic melanomaAndrews, Miles C; Turner, Natalie; Boyd, Janis; Roberts, Andrew W; Grigg, Andrew P ; Behren, Andreas; Cebon, Jonathan S 
817-Dec-2014Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells.Woods, Katherine; Pasam, Anupama; Jayachandran, Aparna; Andrews, Miles C; Cebon, Jonathan S 
910-Nov-2014Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma.Parakh, S ; Murphy, C; Lau, D ; Cebon, Jonathan S ; Andrews, Miles C
103-Jul-2014The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.Vella, Laura J; Andrews, Miles C; Pasam, Anupama; Woods, Katherine; Behren, Andreas; Cebon, Jonathan S 
1117-Jun-2014Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Vella, Laura J; Andrews, Miles C; Behren, Andreas; Cebon, Jonathan S ; Woods, Katherine
121-Jun-2014Evolving role of tumor antigens for future melanoma therapies.Andrews, Miles C; Woods, Katherine; Cebon, Jonathan S ; Behren, Andreas
131-Apr-2014A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.Lau, David K ; Andrews, Miles C; Turner, Natalie; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
144-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S